Skip to content

A prospective randomized controlled clinical trial of Pingmu Decoction combined with acupuncture in the treatment of non-active thyroid-related ophthalmopathy

A prospective randomized controlled clinical trial of Pingmu Decoction combined with acupuncture in the treatment of non-active thyroid-related ophthalmopathy

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2100004405
Enrollment
Unknown
Registered
2020-11-03
Start date
2020-11-07
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thyroid associated ophthalmopathy

Interventions

Sponsors

Longhua Hospital, Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Patients who meet the diagnostic criteria of TCM and Western medicine; 2. Patients aged 19-70 years; 3. Patients who refused surgery; 4. Patients with go history and normal serum thyroid hormone levels (FT3, FT4) for at least two months; 5. Those patients with informed consent, who have good compliance and are willing to accept treatment.

Exclusion criteria

Exclusion criteria: 1. Other causes of exophthalmos: myopic exophthalmos, primary orbital tumor, orbital inflammatory pseudotumor, eye metastases and other diseases; 2. Mental patients; 3. Patients with severe primary and secondary cardiovascular and cerebrovascular diseases, liver and kidney diseases, hematopoietic system diseases, and hyperthyroid crisis tendency; 4. Pregnant or lactating women.

Design outcomes

Primary

MeasureTime frame
TCM syndrome integral;Degree of exophthalmia;

Countries

China

Contacts

Public ContactLi Hong

Longhua Hospital Affiliated to Shanghai University of traditional Chinese Medicine

ltybbw@163.com+86 13127652829

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026